Pyrazinoic Acid

Pyrazinoic Acid

SCHEMBL4699795

NC=O.O=C(O)c1cnccn1

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.80
NAPRT Q6XQN6 2/20 0.80
HCAR2 Q8TDS4 1/20 0.80
TSHR P16473 2/20 0.64
ADORA3 P0DMS8 1/20 0.64
MC4R P32245 1/20 0.64
ADRA1A P35348 1/20 0.64
MC3R P41968 1/20 0.64
BAZ2B Q9UIF8 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.44
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
LMNA P02545 1/20 0.41
P4HTM Q9NXG6 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPT P10636 2/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrazinoic Acid SCHEMBL27659395 0.90 KDM4E (0.91) KDM4ENAPRTHCAR2TSHRADORA3
Pyrazinoic Acid SCHEMBL29651929 0.89
Pyrazinoic Acid SCHEMBL23757 0.89
Pyrazinoic Acid SCHEMBL623119 0.87 KDM4E (0.95) KDM4ENAPRTHCAR2TSHRADORA3
Pyrazinoic Acid SCHEMBL6631652 0.87 KDM4E (0.95) KDM4ENAPRTHCAR2TSHRADORA3
Pyrazinoic Acid SCHEMBL8335237 0.87 KDM4E (0.95) KDM4ENAPRTHCAR2TSHRADORA3
Pyrazinoic Acid SCHEMBL10349317 0.87 KDM4E (0.95) KDM4ENAPRTHCAR2TSHRADORA3
Pyrazinoic Acid SCHEMBL8978502 0.87 KDM4E (0.95) KDM4ENAPRTHCAR2TSHRADORA3
Pyrazinoic Acid SCHEMBL8341710 0.87 KDM4E (0.95) KDM4ENAPRTHCAR2TSHRADORA3
Pyrazinoic Acid SCHEMBL9478203 0.87 KDM4E (0.95) KDM4ENAPRTHCAR2TSHRADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275054-A1 3-(Substituted Amino)-Pyrazolo[3, 4-D]Pyrimidines as Ephb and Vegfr2 Kinase Inhibitors HOLZER PHILIPP 2008-11-06 US disclosed
EP-1963327-A1 3-(SUBSTITUTED AMINO)-PYRAZOLO[3,4-d]PYRIMIDINES AS EPHB AND VEGFR2 KINASE INHIBITORS Novartis AG (CH) 2008-09-03 EP disclosed
WO-2007062805-A1 3-(SUBSTITUTED AMINO)-PYRAZOLO[3,4-d]PYRIMIDINES AS EPHB AND VEGFR2 KINASE INHIBITORS NOVARTIS AG (CH) 2007-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275054-A1 3-(Substituted Amino)-Pyrazolo[3, 4-D]Pyrimidines as Ephb and Vegfr2 Kinase Inhibitors EPHB3, EPHB2, EPHB1 KDM4E 1400/4885NAPRT 1458/4885HCAR2 1488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.